NCT01867814

Brief Summary

Laparoscopic surgery is frequently associated with hemodynamic changes due to pneumoperitoneum (PnP). Those complex hemodynamic changes are difficult to predict and occasionally they require active therapeutic interventions or even interruption of the surgical procedure. One of the main hemodynamic effects of PnP is a decrease in cardiac output due to reduction of venous return and cardiac preload. Although it has been shown repeatedly that waveform variables are good predictors of cardiac output response to volume loading, the prediction hemodynamic response to decrease of preload is more complex. The investigators hypothesize that waveform variables will predict cardiac output changes resulting from PnP. Particularly, augmented values of waveform variables before PnP will be associated with a larger decrease of cardiac output after establishing PnP.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

May 27, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 4, 2013

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

August 5, 2015

Status Verified

August 1, 2015

Enrollment Period

3.5 years

First QC Date

May 27, 2013

Last Update Submit

August 4, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac output/cardiac index

    Cardiac output/cardiac index will be measured before applying of pneumoperitoneum, 2-5 min after applying of pneumoperitoneum with intraabdominal pressure of 15 mmHg and 2-5 min after decrease of intraabdominal pressure until 10 mmHg

    Change of intraabdominal pressure before and 2-5 min after pneumoperitoneum

Secondary Outcomes (1)

  • Systolic pressure variation (SPV)/Pulse pressure variation (PPV)

    Change of intraabdominal pressure before and 2-5 min after pneumoperitoneum

Other Outcomes (1)

  • Plethysmographic Waveform Variation (PWV)

    Change of intraabdominal pressure before and 2-5 min after pneumoperitoneum

Study Arms (1)

Pneumoperitoneum

EXPERIMENTAL

Patients undergoing laparoscopic surgery

Procedure: Pneumoperitoneum

Interventions

Pneumoperitoneum 15 mmHg and 10 mmHg

Pneumoperitoneum

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patients scheduled for elective laparoscopic partial hepatectomy, laparoscopic splenectomy, laparoscopic pancreatectomy - required of continuous direct blood pressure monitoring according to the type of surgery
  • The patients ASA class III-IV scheduled for elective laparoscopic colectomy and hemicolectomy - required of continuous direct blood pressure monitoring according to their medical condition
  • Pneumoperitoneum by needle application only
  • Normal sinus cardiac rhythm

You may not qualify if:

  • Patients that didn't sign informed consent
  • Patients ASA class I-II scheduled for elective laparoscopic colectomy or hemicolectomy
  • Patients scheduled for elective laparoscopic cholecystectomy
  • Patients required of monitoring by pulmonary artery catheter during the surgery according to their medical condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Lady Davis Carmel Medical Center

Haifa, 34362, Israel

RECRUITING

MeSH Terms

Conditions

Pneumoperitoneum

Condition Hierarchy (Ancestors)

Peritoneal DiseasesDigestive System Diseases

Study Officials

  • Pizov Reuven, MD

    Carmel Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2013

First Posted

June 4, 2013

Study Start

May 1, 2013

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

August 5, 2015

Record last verified: 2015-08

Locations